International Federation of Pharmaceutical Manufacturers & Associations

Former CEO and Chairman of the Board of Bayer Pharma AG, Dieter Weinand, Joins Coya’s Board of Directors

Retrieved on: 
Monday, August 21, 2023
Biotechnology, Neurology, Health, Pharmaceutical, Clinical Trials, DNA, Saskatchewan River Sturgeon Management Board, International Federation of Pharmaceutical Manufacturers & Associations, Bayer, United States of Europe, Pharmaceutical Research and Manufacturers of America, Pharmacy, Bristol Myers Squibb, Science, COYA, Regulatory T cell, EFPIA, Regulation, Therapy, Pharmaceutical industry, Pfizer

Coya will leverage Mr. Weinand’s extensive experience, connections, and judgement to guide Coya’s strategic discussions and development programs.

Key Points: 
  • Coya will leverage Mr. Weinand’s extensive experience, connections, and judgement to guide Coya’s strategic discussions and development programs.
  • Mr. Weinand presently serves as the Chairman of the Board of Directors of Replimune Group Inc. (NASDAQ: REPL), Mnemo Therapeutics, Umoja Biopharma, Inc., Inspirna, Inc., and Ziel Bio, Inc.
  • Previously, Mr. Weinand was Chief Executive Officer and Chairman of the Board of Bayer Pharma AG and member of the Management Board at Bayer AG.
  • Prior to his work at Bayer, Mr. Weinand held various positions in commercial, operational, and strategic areas of the pharmaceutical industry.

Cocrystal Pharma Appoints Pharma Industry Veteran Fred Hassan to its Board of Directors

Retrieved on: 
Monday, April 24, 2023
Cocrystal, University, Pharmaceutical Research and Manufacturers of America, BS, Avon Products, Pharmacia, Kirin-Amgen Inc v Hoechst Marion Roussel Ltd, Schering-Plough, Pharmacia & Upjohn, Bausch, Medication, International Federation of Pharmaceutical Manufacturers & Associations, Coronavirus Scientific Advisory Board, Pharmacy, Novartis, MBA, Doctor of Philosophy, Bausch & Lomb, WarnerMedia, Organization, Warburg Pincus, Chemical engineering, Monsanto, Harvard Business School, Merck, Imperial College London, COCP, Management

BOTHELL, Wash., April 24, 2023 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (Cocrystal or the Company) announces the appointment of Fred Hassan to its Board of Directors, increasing its Board membership to six.

Key Points: 
  • BOTHELL, Wash., April 24, 2023 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (Cocrystal or the Company) announces the appointment of Fred Hassan to its Board of Directors, increasing its Board membership to six.
  • Mr. Hassan’s distinguished 40-year career includes serving in senior executive and director positions at global pharmaceutical companies and leading investment firms.
  • Earlier this month, Cocrystal announced Mr. Hassan’s $2 million investment in the Company through an at-the-market private placement.
  • “It’s an honor to attract such a highly accomplished industry veteran to our Board,” said Roger Kornberg, PhD, Cocrystal Chairman, Chief Scientist and Chairman of the Scientific Advisory Board.

Clinical Trials Management System Market Worth $4.72 Billion by 2030: Grand View Research, Inc.

Retrieved on: 
Monday, January 16, 2023
Cloud, International Federation of Pharmaceutical Manufacturers & Associations, Patient safety, CTMS, Clinical trial, ML, Medication, COVID-19, Cros, Clinical trial management system, Biotechnology, IQVIA, Machine learning, Research, Conditional sentence, Neurology, Vaccine, AI, Calendar, Drug development, Infection, Software, EDC, Prevalence, Component, Oracle, Cancer, Revenue, SAN, EHR, USD, Investment, Pharmaceutical industry, Medical device, Generic drug

The key factors driving the market growth include the rising number of clinical trials, digitalization across healthcare R&D, number of decentralized trials, and product enhancements.

Key Points: 
  • The key factors driving the market growth include the rising number of clinical trials, digitalization across healthcare R&D, number of decentralized trials, and product enhancements.
  • Key Industry Insights & Findings from the report:
    The Clinical Trials Management System (CTMS) market was valued at USD 1.66 billion in 2022 and is expected to expand at a CAGR of 14.3% during the forecast period.
  • Clinical Trial Management System is one of the three applications of IQVIA's Digital Trial Management Suite.
  • Grand View Research has segmented the clinical trials management system market based on solution type, delivery mode, component, end-user, and region
    Clinical Trials Management System (CTMS) Market - Solution Type Outlook (Revenue, USD Million, 2017 - 2030)
    Clinical Trials Management System (CTMS) Market - Delivery Mode Outlook (Revenue, USD Million, 2017 - 2030)
    Clinical Trials Management System (CTMS) Market - Component Outlook (Revenue, USD Million, 2017 - 2030)
    Clinical Trials Management System (CTMS) Market - End-user Outlook (Revenue, USD Million, 2017 - 2030)

Clinical Trials Management System Market Worth $4.72 Billion by 2030: Grand View Research, Inc.

Retrieved on: 
Monday, January 16, 2023
Cloud, International Federation of Pharmaceutical Manufacturers & Associations, Patient safety, CTMS, Clinical trial, ML, Medication, COVID-19, Cros, Clinical trial management system, Biotechnology, IQVIA, Machine learning, Research, Conditional sentence, Neurology, Vaccine, AI, Calendar, Drug development, Infection, Software, EDC, Prevalence, Component, Oracle, Cancer, Revenue, SAN, EHR, USD, Investment, Pharmaceutical industry, Medical device, Generic drug

The key factors driving the market growth include the rising number of clinical trials, digitalization across healthcare R&D, number of decentralized trials, and product enhancements.

Key Points: 
  • The key factors driving the market growth include the rising number of clinical trials, digitalization across healthcare R&D, number of decentralized trials, and product enhancements.
  • Key Industry Insights & Findings from the report:
    The Clinical Trials Management System (CTMS) market was valued at USD 1.66 billion in 2022 and is expected to expand at a CAGR of 14.3% during the forecast period.
  • Clinical Trial Management System is one of the three applications of IQVIA's Digital Trial Management Suite.
  • Grand View Research has segmented the clinical trials management system market based on solution type, delivery mode, component, end-user, and region
    Clinical Trials Management System (CTMS) Market - Solution Type Outlook (Revenue, USD Million, 2017 - 2030)
    Clinical Trials Management System (CTMS) Market - Delivery Mode Outlook (Revenue, USD Million, 2017 - 2030)
    Clinical Trials Management System (CTMS) Market - Component Outlook (Revenue, USD Million, 2017 - 2030)
    Clinical Trials Management System (CTMS) Market - End-user Outlook (Revenue, USD Million, 2017 - 2030)

Global Health Progress Launched to Drive Cross-sectoral Collaborations in Support of the Sustainable Development Goals (SDGs)

Retrieved on: 
Friday, October 25, 2019
Biotechnology, Pharmaceutical, Health, Other Health, International Federation of Pharmaceutical Manufacturers & Associations, Pharmaceutical industry, Sustainable Development Goals, Global health, Articles

To support the SDGs, with a particular focus on SDG 17: Partnership for The Goals, the International Federation of Pharmaceutical Manufacturers & Associations ( IFPMA ) has launched Global Health Progress.

Key Points: 
  • To support the SDGs, with a particular focus on SDG 17: Partnership for The Goals, the International Federation of Pharmaceutical Manufacturers & Associations ( IFPMA ) has launched Global Health Progress.
  • Countries have made progress towards achieving the goals; however, complex health and wellbeing challenges remain from poverty and inequality to climate change.
  • Global Health Progress highlights over 200 collaborations which use innovative approaches to tackle global health challenges.
  • For more information, visit Global Health Progress at www.globalhealthprogress.org
    IFPMA represents innovative biopharmaceutical companies and associations across the globe.

R&D biopharmaceutical industry embraces NEW Code of Practice to boost business integrity worldwide

Retrieved on: 
Thursday, January 10, 2019
Health, Clinical trials, Hospitals, Pharmaceutical, Research, Science, General Health, Pharmaceutical industry, Biotechnology, International Federation of Pharmaceutical Manufacturers & Associations, Health, Pharmacology, Biopharmaceutical, Pharmaceutical marketing

We are glad to see that the new pharma industry Code of Practice is value-based, this will lead to the right instinct to put the patient first.

Key Points: 
  • We are glad to see that the new pharma industry Code of Practice is value-based, this will lead to the right instinct to put the patient first.
  • Reflecting the unique role played by the research-based biopharmaceutical industry, the first international self-regulation mechanism in the biopharmaceutical industry was put in place in 1981, called the IFPMA Code of Pharmaceutical Marketing Practice.
  • Since then, the Code has been revised five times, to ensure that the biopharmaceutical industry remains consistent with societys changing needs and expectations.
  • With the latest edition of IFPMA Code of Practice, the bar to meet expectations regarding compliance is set even higher.

The global clinical trials management system (CTMS) market size is expected to reach USD 1.62 billion by 2025

Retrieved on: 
Tuesday, November 27, 2018
Health, Clinical research, Pharmaceutical industry, Medical research, Clinical data management, Clinical trials, Clinical trial management system, International Federation of Pharmaceutical Manufacturers & Associations, Pharmaceuticals policy, Clinical trial, Contract research organization

NEW YORK, Nov. 27, 2018 /PRNewswire/ -- Clinical Trials Management System (CTMS) Market Share, Size & Trends Analysis Report By Type (Enterprise, Site), By Delivery Mode (Web-based, Cloud-based), By Component, By End User, And Segment Forecasts, 2018 - 2025

Key Points: 
  • NEW YORK, Nov. 27, 2018 /PRNewswire/ -- Clinical Trials Management System (CTMS) Market Share, Size & Trends Analysis Report By Type (Enterprise, Site), By Delivery Mode (Web-based, Cloud-based), By Component, By End User, And Segment Forecasts, 2018 - 2025
    The global clinical trials management system (CTMS) market size is expected to reach USD 1.62 billion by 2025, according to a new report by Grand View Research, Inc.
  • Rapid growth of healthcare IT, high R&D expenditure by life science and clinical research organizations, and adoption of CTMS solutions is anticipated to drive the market growth.
  • This factor is expected to boostgrowth of the market for clinical trial management systems.According to the estimates of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), global research-based pharmaceutical industry has spent around USD 149.8 billion in 2015.
  • Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.